Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
INFINITY PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 90K | Mar 30, 2022 | Direct | ||
MEI Pharma, Inc. | Director | Stock Option (Right to Buy) | 10K | Sep 29, 2023 | Direct | ||
ACCELERON PHARMA INC | EVP, Chief Commercial Officer | Common Stock | 0 | $29.37 | Nov 19, 2021 | Direct | |
ACCELERON PHARMA INC | EVP, Chief Commercial Officer | Option to Purchase Common Stock | 0 | Nov 19, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MEIP | MEI Pharma, Inc. | Sep 29, 2023 | 1 | $0 | 4 | Oct 12, 2023 | Director |
MEIP | MEI Pharma, Inc. | Jul 5, 2022 | 1 | $0 | 4 | Jul 7, 2022 | Director |
INFI | INFINITY PHARMACEUTICALS, INC. | Mar 30, 2022 | 1 | $0 | 4 | Mar 31, 2022 | Director |
INFI | INFINITY PHARMACEUTICALS, INC. | Mar 30, 2022 | 0 | $0 | 3 | Mar 31, 2022 | Director |
MEIP | MEI Pharma, Inc. | Nov 22, 2021 | 1 | $0 | 4 | Nov 23, 2021 | Director |
MEIP | MEI Pharma, Inc. | Nov 22, 2021 | 0 | $0 | 3 | Nov 23, 2021 | Director |
XLRN | ACCELERON PHARMA INC | Nov 19, 2021 | 5 | $0 | 4 | Nov 22, 2021 | EVP, Chief Commercial Officer |
XLRN | ACCELERON PHARMA INC | Sep 27, 2021 | 3 | -$672K | 4 | Sep 27, 2021 | EVP, Chief Commercial Officer |
XLRN | ACCELERON PHARMA INC | Sep 21, 2021 | 3 | -$547K | 4 | Sep 22, 2021 | EVP, Chief Commercial Officer |
XLRN | ACCELERON PHARMA INC | Feb 12, 2021 | 1 | -$116K | 4 | Jun 8, 2021 | EVP, Chief Commercial Officer |